Literature DB >> 24295812

Respiratory dysfunction in unsedated dogs with golden retriever muscular dystrophy.

Justin C DeVanna1, Joe N Kornegay2, Daniel J Bogan2, Janet R Bogan2, Jennifer L Dow2, Eleanor C Hawkins3.   

Abstract

Golden retriever muscular dystrophy (GRMD) is a well-established model of Duchenne muscular dystrophy. The value of this model would be greatly enhanced with practical tools to monitor progression of respiratory dysfunction during treatment trials. Arterial blood gas analysis, tidal breathing spirometry, and respiratory inductance plethysmography (RIP) were performed to determine if quantifiable abnormalities could be identified in unsedated, untrained, GRMD dogs. Results from 11 dogs with a mild phenotype of GRMD and 11 age-matched carriers were compared. Arterial blood gas analysis was successfully performed in all dogs, spirometry in 21 of 22 (95%) dogs, and RIP in 18 of 20 (90%) dogs. Partial pressure of carbon dioxide and bicarbonate concentration were higher in GRMD dogs. Tidal breathing peak expiratory flows were markedly higher in GRMD dogs. Abnormal abdominal motion was present in 7 of 10 (70%) GRMD dogs. Each technique provided objective, quantifiable measures that will be useful for monitoring respiratory function in GRMD dogs during clinical trials while avoiding the influence of sedation on results. Increased expiratory flows and the pattern of abdominal breathing are novel findings, not reported in people with Duchenne muscular dystrophy, and might be a consequence of hyperinflation.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Blood gas analysis; Flow-volume loop; Golden retriever muscular dystrophy; Muscular dystrophy; Pulmonary function test; Respiratory inductance plethysmography; Spirometry

Mesh:

Year:  2013        PMID: 24295812      PMCID: PMC3911885          DOI: 10.1016/j.nmd.2013.10.001

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  59 in total

Review 1.  Disorders of the respiratory muscles.

Authors:  Franco Laghi; Martin J Tobin
Journal:  Am J Respir Crit Care Med       Date:  2003-07-01       Impact factor: 21.405

Review 2.  Pulmonary manifestations of neuromuscular disease with special reference to Duchenne muscular dystrophy and spinal muscular atrophy.

Authors:  D Gozal
Journal:  Pediatr Pulmonol       Date:  2000-02

3.  Changes in spirometry over time as a prognostic marker in patients with Duchenne muscular dystrophy.

Authors:  M F Phillips; R C Quinlivan; R H Edwards; P M Calverley
Journal:  Am J Respir Crit Care Med       Date:  2001-12-15       Impact factor: 21.405

4.  Lung function in children with Duchenne's muscular dystrophy.

Authors:  S Tangsrud; I L Petersen; K C Lødrup Carlsen; K H Carlsen
Journal:  Respir Med       Date:  2001-11       Impact factor: 3.415

5.  Measurement of the separate volume changes of rib cage and abdomen during breathing.

Authors:  K Konno; J Mead
Journal:  J Appl Physiol       Date:  1967-03       Impact factor: 3.531

6.  Pulmonary function in Duchenne muscular dystrophy related to stage of disease.

Authors:  S R Inkley; F C Oldenburg; P J Vignos
Journal:  Am J Med       Date:  1974-03       Impact factor: 4.965

7.  Incidence of Duchenne muscular dystrophy in New South Wales and Australian Capital Territory.

Authors:  J Cowan; J Macdessi; A Stark; G Morgan
Journal:  J Med Genet       Date:  1980-08       Impact factor: 6.318

8.  Asynchronous breathing movements in patients with chronic obstructive pulmonary disease.

Authors:  K Ashutosh; R Gilbert; J H Auchincloss; D Peppi
Journal:  Chest       Date:  1975-05       Impact factor: 9.410

Review 9.  Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care.

Authors:  Katharine Bushby; Richard Finkel; David J Birnkrant; Laura E Case; Paula R Clemens; Linda Cripe; Ajay Kaul; Kathi Kinnett; Craig McDonald; Shree Pandya; James Poysky; Frederic Shapiro; Jean Tomezsko; Carolyn Constantin
Journal:  Lancet Neurol       Date:  2009-11-27       Impact factor: 44.182

10.  The cranial sartorius muscle undergoes true hypertrophy in dogs with golden retriever muscular dystrophy.

Authors:  Joe N Kornegay; Diane D Cundiff; Daniel J Bogan; Janet R Bogan; Carol S Okamura
Journal:  Neuromuscul Disord       Date:  2003-08       Impact factor: 4.296

View more
  8 in total

1.  Laminin-111 protein therapy enhances muscle regeneration and repair in the GRMD dog model of Duchenne muscular dystrophy.

Authors:  Pamela Barraza-Flores; Tatiana M Fontelonga; Ryan D Wuebbles; Hailey J Hermann; Andreia M Nunes; Joe N Kornegay; Dean J Burkin
Journal:  Hum Mol Genet       Date:  2019-08-15       Impact factor: 6.150

2.  Expiratory dysfunction in young dogs with golden retriever muscular dystrophy.

Authors:  Eleanor C Hawkins; Amanda K Bettis; Joe N Kornegay
Journal:  Neuromuscul Disord       Date:  2020-09-20       Impact factor: 4.296

Review 3.  Dystrophin-deficient large animal models: translational research and exon skipping.

Authors:  Xinran Yu; Bo Bao; Yusuke Echigoya; Toshifumi Yokota
Journal:  Am J Transl Res       Date:  2015-08-15       Impact factor: 4.060

Review 4.  Breathing in Duchenne muscular dystrophy: translation to therapy.

Authors:  Doreen Z Mhandire; David P Burns; Angela L Roger; Ken D O'Halloran; Mai K ElMallah
Journal:  J Physiol       Date:  2022-06-24       Impact factor: 6.228

Review 5.  Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials.

Authors:  Joe N Kornegay; Christopher F Spurney; Peter P Nghiem; Candice L Brinkmeyer-Langford; Eric P Hoffman; Kanneboyina Nagaraju
Journal:  ILAR J       Date:  2014

6.  The Dog Model in the Spotlight: Legacy of a Trustful Cooperation.

Authors:  Inès Barthélémy; Christophe Hitte; Laurent Tiret
Journal:  J Neuromuscul Dis       Date:  2019

7.  Non-Invasive Optical Motion Tracking Allows Monitoring of Respiratory Dynamics in Dystrophin-Deficient Mice.

Authors:  Angelika Svetlove; Jonas Albers; Swen Hülsmann; Marietta Andrea Markus; Jana Zschüntzsch; Frauke Alves; Christian Dullin
Journal:  Cells       Date:  2022-03-07       Impact factor: 6.600

8.  X-linked muscular dystrophy in a Labrador Retriever strain: phenotypic and molecular characterisation.

Authors:  Inès Barthélémy; Nadège Calmels; Robert B Weiss; Laurent Tiret; Adeline Vulin; Nicolas Wein; Cécile Peccate; Carole Drougard; Christophe Beroud; Nathalie Deburgrave; Jean-Laurent Thibaud; Catherine Escriou; Isabel Punzón; Luis Garcia; Jean-Claude Kaplan; Kevin M Flanigan; France Leturcq; Stéphane Blot
Journal:  Skelet Muscle       Date:  2020-08-07       Impact factor: 4.912

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.